Ceres Nanosciences is a company based in Northern Virginia, USA, developing products based on its proprietary Nanotrap particles enable the efficient enrichment and stabilization of rare biomarkers. By selectively binding circulating nucleic acids, proteins, and exosomes, they help protect target molecules from degradation. The technology improves sensitivity and reproducibility in research and diagnostic workflows, including liquid biopsy and cfDNA-/cfRNA-based applications in oncology and molecular biology.
Supplier homepage:
https://www.ceresnano.com/
